期刊文献+

Osteoporosis:A Silent Disease with Complex Genetic Contribution 被引量:15

Osteoporosis: A Silent Disease with Complex Genetic Contribution
原文传递
导出
摘要 Osteoporosis is the most common multifactorial metabolic bone disorder worldwide with a strong genetic component. In this review, the evidence for a genetic contribution to osteoporosis and related phenotypes is summarized alongside with methods used to identify osteoporosis susceptibility genes. The key biological pathways involved in the skeleton and bone development are discussed with a particular focus on master genes clustered in these pathways and their mode of action. Furthermore, the most studied single nucleotide polymorphisms (SNPs) analyzed for their importance as genetic markers of the disease are presented. New data generated by next- generation sequencing in conjunction with extensive meta-analyses should contribute to a better understanding of the genetic basis of osteoporosis and related phenotype variability. These data could be ultimately used for identifying at-risk patients for disease prevention by both controlling environmental factors and providing possible therapeutic targets. Osteoporosis is the most common multifactorial metabolic bone disorder worldwide with a strong genetic component. In this review, the evidence for a genetic contribution to osteoporosis and related phenotypes is summarized alongside with methods used to identify osteoporosis susceptibility genes. The key biological pathways involved in the skeleton and bone development are discussed with a particular focus on master genes clustered in these pathways and their mode of action. Furthermore, the most studied single nucleotide polymorphisms (SNPs) analyzed for their importance as genetic markers of the disease are presented. New data generated by next- generation sequencing in conjunction with extensive meta-analyses should contribute to a better understanding of the genetic basis of osteoporosis and related phenotype variability. These data could be ultimately used for identifying at-risk patients for disease prevention by both controlling environmental factors and providing possible therapeutic targets.
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2016年第2期49-61,共13页 遗传学报(英文版)
关键词 OSTEOPOROSIS Bone mineral density Regulatory pathways Single nucleotide polymorphisms Osteoporosis Bone mineral density Regulatory pathways Single nucleotide polymorphisms
  • 相关文献

参考文献112

  • 1Albagha, O.M., Wani, S.E., Visconti, M.R., Alonso, N., Goodman, K., Brandi, M.L., Cundy, T., Chung, P.Y., Dargie, R., Devogelaer, J.E,Falchetti, A., Fraser, W.D., Gennari, L., Gianfrancesco, F., Hooper, M.J., Van Hul, W., lsaia, G., Nicholson, G.C., Nuti, R., Papapoulos, S., Montes, J.del P., Ratajczak, T., Rea, S.L., Rendina, D., Gonzalez- Sarmiento, R., Di Stefano, M., Ward, L.C., Walsh, J.P., Ralston, S.H., Genetic Determinants of Paget's Disease (GDPD) Consortium, 2011. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat. Genet. 43, 685-689.
  • 2Angers, S., Moon, R.T., 2009. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10, 468-477.
  • 3Ardawi, M.S.M., Maimany, A.A., Bahksh, T.M., Nasrat, H.A.N., Milaat, W.A., A1-Raddadi, R.M., 2005. Bone mineral density of the spine and femur in healthy Saudis. Osteoporos. Int. 16, 43-55.
  • 4Arnold, M.A., Kim, Y., Czubryt, M.E, Phan, D., McAnally, J., Qi, X., Shelton, J.M., Richardson, J.A., Bassel-Duby, R., Olson, E.N., 2007. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Ceil 12, 377-389.
  • 5Ashford, R.U., Luchetti, M., McCloskey, E.Vi, Gray, R.L., Pande, K.C., Dey, A., Kayan, K., Ralston, S.H., Kanis, J.A., 2001. Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I alpha 1 alleles in elderly women. Calcif. Tissue Int. 68, 348-351.
  • 6Aspray, T.J., 2015. Fragility fracture: recent developments in risk assessment. Ther. Adv. Musculoskelet. Dis. 7, 17-25.
  • 7Balemans, W., Ebeling, M., Patel, N., Van Hul, E., Olson, P., Dioszegi, M., Laeza, C., Wuyts, W., Van Den Ende, J., Willems, P., Paes-Alves, A.F., Hill, S., Bueno, M., Ramos, F.J., Tacconi, P., Dikkers, EG., Stratakis, C., Lindpainmer, K., Vickery, B., Foernzler, D., Van Hul, W., 2001. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537-543.
  • 8Banziger, C., Soldini, D., Schutt, C., Zipperlen, P., Hausmann, G., Basler, K., 2006. Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125, 509-522.
  • 9Batra, G.S., Hainey, L., Freemont, A.J., Andrew, G., Saunders, P.T., Hoyland, J.A., Braidman, I.P., 2003. Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women. J. Pathol. 200, 65-73.
  • 10Berg, J.P., Lehmann, E.H., Stakkestad, J.A., Haug, E., Halse, J., 2000. The Spl binding site polymorphism in the collagen type I alpha 1 (COLIA1) gene is not associated with bone mineral density in healthy children, adolescents, and young adults. Eur. J. Endocrinol. 143, 261-265.

同被引文献98

引证文献15

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部